help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabbour, H. N.
Right arrow Articles by Boddy, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jabbour, H. N.
Right arrow Articles by Boddy, S. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 9 4481-4487
Copyright © 2003 by The Endocrine Society

Prostaglandin E2 Induces Proliferation of Glandular Epithelial Cells of the Human Endometrium via Extracellular Regulated Kinase 1/2-Mediated Pathway

H. N. Jabbour and S. C. Boddy

Medical Research Council Human Reproductive Sciences Unit, The University of Edinburgh Academic Centre, Edinburgh, Scotland EH16 4SB, United Kingdom

Address all correspondence and requests for reprints to: Dr. Henry N. Jabbour, Medical Research Council Human Reproductive Sciences Unit, The University of Edinburgh Academic Centre, Chancellor’s Building, 49 Little France Crescent, Edinburgh, Scotland EH16 4SB, United Kingdom. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.

In this study, we investigated the effect of prostaglandin E2 (PGE2) on MAPK ERK1/2 protein phosphorylation and on proliferation of epithelial cells of the human endometrium. Treatment of proliferative phase endometrium with PGE2 induced rapid phosphorylation of ERK1/2 proteins in glandular epithelial and endothelial cells. Treatment of human endometrial tissue with PGE2 for 24 h resulted in increased incorporation of 5-bromo-2'-deoxyuridine (a marker of cellular proliferation) in glandular epithelial cells. To investigate further the effect of PGE2 on proliferation of epithelial cells, we used an endometrial epithelial cell line (HES). HES cells express functional EP4 (with absence of expression of EP1, EP2, and EP3) receptors and stimulate cAMP release and rapid phosphorylation of ERK1/2 proteins in response to PGE2 or forskolin. Treatment of HES cells with PGE2 or forskolin alone resulted in a significant increase in HES cell proliferation compared with control untreated cells (P < 0.05). Cotreatment of the cells with PGE2 or forskolin and PD98059 abolished the increase in cellular proliferation. These data demonstrate ERK1/2 phosphorylation in response to PGE2 in the human endometrium and suggest that PGE2 via EP4 receptor may induce glandular epithelial cell proliferation in ERK1/2- dependent manner during the proliferative phase of the menstrual cycle.

Abbreviations: BrdU, 5-Bromo-2'-deoxyuridine; COX, cyclooxygenase; EP1-EP4, four receptor subtypes for PGE2; HES, endometrial epithelial cell line; PGE, prostaglandin E; PGH2, prostaglandin H2.




This article has been cited by other articles:


Home page
EndocrinologyHome page
I. Gashaw, S. Stiller, C. Boing, R. Kimmig, and E. Winterhager
Premenstrual Regulation of the Pro-Angiogenic Factor CYR61 in Human Endometrium
Endocrinology, May 1, 2008; 149(5): 2261 - 2269.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. H. C. Kengni, I. St-Louis, S. Parent, V. Leblanc, C. Shooner, and E. Asselin
Regulation of prostaglandin D synthase and prostacyclin synthase in the endometrium of cyclic, pregnant, and pseudopregnant rats and their regulation by sex steroids
J. Endocrinol., November 1, 2007; 195(2): 301 - 311.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. D. Stoner, H. Qin, T. Chen, P. S. Carlton, M. E. Rose, R. M. Aziz, and R. Dixit
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis
Carcinogenesis, September 1, 2005; 26(9): 1590 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Nicola, A. V. Timoshenko, S. J. Dixon, P. K. Lala, and C. Chakraborty
EP1 Receptor-Mediated Migration of the First Trimester Human Extravillous Trophoblast: The Role of Intracellular Calcium and Calpain
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4736 - 4746.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.L. Hull, A. Prentice, D.Y. Wang, R.P. Butt, S.C. Phillips, S.K. Smith, and D.S. Charnock-Jones
Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
Hum. Reprod., February 1, 2005; 20(2): 350 - 358.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S Battersby, H O D Critchley, A J de Brum-Fernandes, and H N Jabbour
Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle
Reproduction, January 1, 2004; 127(1): 79 - 86.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society